References
- 1Mėlinytė-Ankudavičė K, Bučius P, Mizarienė V, Lapinskas T, Šakalytė G, Plisienė J, et al. Association of whole-heart myocardial mechanics by transthoracic echocardiography with presence of late gadolinium enhancement by CMR in non-ischemic dilated cardiomyopathy. Journal of Clinical Medicine. 2022; 11(22): 6607. DOI: 10.3390/jcm11226607
- 2Huang Y, Wang H-Y, Jian W, Yang Z-J, Gui C. Development and validation of a nomogram to predict the risk of death within 1 year in patients with non-ischemic dilated cardiomyopathy: A retrospective cohort study. Scientific Reports. 2022; 12(1): 8513. DOI: 10.1038/s41598-022-12249-7
- 3Akhtar M, Elliott P. Risk stratification for sudden cardiac death in non-ischaemic dilated cardiomyopathy. Current Cardiology Reports. 2019; 21: 1–8. DOI: 10.1007/s11886-019-1236-3
- 4Minja NW, Nakagaayi D, Aliku TO, Zhang W, Ssinabulya I, Nabaale J, et al. Cardiovascular diseases in Africa in the 21st century: Gaps and priorities going forward. Frontiers in Cardiovascular Medicine. 2022; 3262. DOI: 10.3389/fcvm.2022.1008335
- 5Yuyun MF, Sliwa K, Kengne AP, Mocumbi AO, Bukhman G. Cardiovascular diseases in Sub-Saharan Africa compared to high-income countries: an epidemiological perspective. Global heart. 2020; 15(1). DOI: 10.5334/gh.808
- 6Fundikira LS, Chillo P, Mutagaywa R, Kamuhabwa A, Kwesigabo G, Asselbergs F, et al. Risk factors and prevalence of dilated cardiomyopathy in sub-saharan africa: A systematic review. Global Heart. 2022; 17(1). DOI: 10.5334/gh.1166
- 7Taylor MR, Carniel E, Mestroni L. Cardiomyopathy, familial dilated. Orphanet Journal of Rare Diseases. 2006; 1(1): 1–8. DOI: 10.1186/1750-1172-1-27
- 8Moretti M, Merlo M, Barbati G, Di Lenarda A, Brun F, Pinamonti B, et al. Prognostic impact of familial screening in dilated cardiomyopathy. European Journal of Heart Failure. 2010; 12(9): 922–7. DOI: 10.1093/eurjhf/hfq093
- 9Jansweijer JA, Hershberger R, Van Spaendonck KY. Dilated cardiomyopathy. Clinical Cardiogenetics: Second Edition. 2016: 75–89. DOI: 10.1007/978-3-319-44203-7_5
- 10Makubi A, Hage C, Lwakatare J, Kisenge P, Makani J, Rydén L, et al. Contemporary aetiology, clinical characteristics and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: The prospective Tanzania Heart Failure (TaHeF) study. Heart. 2014; 100(16): 1235–41. DOI: 10.1136/heartjnl-2014-305599
- 11Pallangyo P, Millinga J, Bhalia S, Mkojera Z, Misidai N, Swai HJ, et al. Medication adherence and survival among hospitalized heart failure patients in a tertiary hospital in Tanzania: A prospective cohort study. BMC Research Notes. 2020; 13: 1–8. DOI: 10.1186/s13104-020-04959-w
- 12McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2021; 42(36): 3599–726. DOI: 10.1093/eurheartj/ehab368
- 13Sánchez MA, Pineda SO. Diagnosis and therapy for diastolic heart failure. Revista Española de Cardiología (English Edition). 2004; 57(6): 570–5. DOI: 10.1016/S1885-5857(06)60631-2
- 14Messerli FH, Rimoldi SF, Bangalore S. The transition from hypertension to heart failure: contemporary update. JACC: Heart Failure. 2017; 5(8): 543–51. DOI: 10.1016/j.jchf.2017.04.012
- 15Sliwa K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, Maggioni AP, Laroche C, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM) EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. European Journal of Heart Failure. 2017; 19(9): 1131–41. DOI: 10.1002/ejhf.780
- 16Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association. Circulation. 2016; 134(23): e579–e646. DOI: 10.1161/CIR.0000000000000455
- 17Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. European Heart Journal. 2016; 37(23): 1850–8. DOI: 10.1093/eurheartj/ehv727
- 18Organization WH. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. World Health Organization; 2011.
- 19Shah BN. On the 50th anniversary of the first description of a multistage exercise treadmill test: Re-visiting the birth of the ‘Bruce protocol’. BMJ Publishing Group Ltd and British Cardiovascular Society; 2013. pp. 1793–4. DOI: 10.1136/heartjnl-2013-304003
- 20Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mähönen M, Ngu Blackett K, et al. World Health Organization definition of myocardial infarction: 2008–09 revision. International Journal of Epidemiology. 2011; 40(1): 139–46. DOI: 10.1093/ije/dyq165
- 21Alghamdi SS, Abdelaziz I, Albadri M, Alyanbaawi S, Aljondi R, Tajaldeen A. Study of cardiomegaly using chest x-ray. Journal of Radiation Research and Applied Sciences. 2020; 13(1): 460–7. DOI: 10.1080/16878507.2020.1756187
- 22Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the european association of cardiovascular imaging. European Heart Journal-Cardiovascular Imaging. 2015; 16(3): 233–71. DOI: 10.1093/ehjci/jev014
- 23Shahgaldi K, Gudmundsson P, Manouras A, Brodin L-Å, Winter R. Visually estimated ejection fraction by two dimensional and triplane echocardiography is closely correlated with quantitative ejection fraction by real-time three dimensional echocardiography. Cardiovascular Ultrasound. 2009; 7(1): 1–7. DOI: 10.1186/1476-7120-7-41
- 24Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics. 2019; 95: 103208. DOI: 10.1016/j.jbi.2019.103208
- 25Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, et al. Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF. JACC: Heart Failure. 2019; 7(6): 457–65. DOI: 10.1016/j.jchf.2019.02.015
- 26Makubi A, Hage C, Sartipy U, Lwakatare J, Janabi M, Kisenge P, et al. Heart failure in Tanzania and Sweden: comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF). International Journal of Cardiology. 2016; 220: 750–8. DOI: 10.1016/j.ijcard.2016.06.239
- 27Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Heart failure in Africa, Asia, the Middle East and South America: the INTER-CHF study. International Journal of Cardiology. 2016; 204: 133–41. DOI: 10.1016/j.ijcard.2015.11.183
- 28Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update: A report from the American Heart Association. Circulation. 2017; 135(10): e146–e603. DOI: 10.1161/CIR.0000000000000491
- 29Noma M, Khali SI, Atabani SM, Homeida M. Prevalence and clinical presentations of dilated cardiomyopathy in sudanese patients with heart failure. Open Science Journal. 2017; 2(4). DOI: 10.23954/osj.v2i4.1174
- 30Ware JS, Amor-Salamanca A, Tayal U, Govind R, Serrano I, Salazar-Mendiguchía J, et al. Genetic etiology for alcohol-induced cardiac toxicity. Journal of the American College of Cardiology. 2018; 71(20): 2293–302. DOI: 10.1016/j.jacc.2018.03.462
- 31Rayner JJ, Abdesselam I, d’Arcy J, Myerson SG, Neubauer S, Watkins H, et al. Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy. Cardiovascular Diagnosis and Therapy. 2020; 10(3): 559. DOI: 10.21037/cdt-19-587
- 32Evangelista I, Nuti R, Picchioni T, Dotta F, Palazzuoli A. Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy. International Journal of Molecular Sciences. 2019; 20(13): 3264. DOI: 10.3390/ijms20133264
- 33Shen M-T, Li Y, Guo Y-K, Jiang L, Gao Y, Shi R, et al. Impact of type 2 diabetes mellitus on left ventricular deformation in non-ischemic dilated cardiomyopathy patients assessed by cardiac magnetic resonance imaging. Cardiovascular Diabetology. 2022; 21(1): 1–12. DOI: 10.1186/s12933-022-01533-5
- 34Park J, Lee H-J, Kim SK, Yi J-E, Shin DG, Lee JM, et al. Smoking aggravates ventricular arrhythmic events in non-ischemic dilated cardiomyopathy associated with a late gadolinium enhancement in cardiac MRI. Scientific reports. 2018; 8(1): 15609. DOI: 10.1038/s41598-018-34145-9
- 35Kayvanpour E, Sedaghat-Hamedani F, Amr A, Lai A, Haas J, Holzer DB, et al. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clinical Research in Cardiology. 2017; 106: 127–39. DOI: 10.1007/s00392-016-1033-6
- 36Bailly C, Henriques S, Tsabedze N, Krause A. Role of family history and clinical screening in the identification of families with idiopathic dilated cardiomyopathy in Johannesburg, South Africa. South African Medical Journal. 2019; 109(9): 673–8. DOI: 10.7196/SAMJ.2019.v109i9.13936
- 37Fundikira LS, Julius J, Chillo P, Mayala H, Kifai E, van Laake LW, et al. Yield of family screening in dilated cardiomyopathy within low-income setting: Tanzanian experience. Cardiovasc J Afr. 2023; 34: 1–6.
- 38Karaye KM, Sani MU. Factors associated with poor prognosis among patients admitted with heart failure in a Nigerian tertiary medical centre: a cross-sectional study. BMC Cardiovascular Disorders. 2008; 8: 1–8. DOI: 10.1186/1471-2261-8-16
- 39Ersbøll AS, Johansen M, Damm P, Rasmussen S, Vejlstrup NG, Gustafsson F. Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome. European Journal of Heart Failure. 2017; 19(12): 1712–20. DOI: 10.1002/ejhf.882
- 40Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu J-WY, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. The American Journal of Cardiology. 2007; 100(2): 302–4. DOI: 10.1016/j.amjcard.2007.02.092
- 41Ntusi NA. HIV and myocarditis. Current Opinion in HIV and AIDS. 2017; 12(6): 561–5. DOI: 10.1097/COH.0000000000000416
- 42Asselbergs FW, Sammani A, Elliott P, Gimeno JR, Tavazzi L, Tendera M, et al. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry. ESC Heart Failure. 2021; 8(1): 95–105. DOI: 10.1002/ehf2.13100
- 43Klem I, Shah DJ, White RD, Pennell DJ, Van Rossum AC, Regenfus M, et al. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Circulation: Cardiovascular Imaging. 2011; 4(6): 610–9. DOI: 10.1161/CIRCIMAGING.111.964965
- 44Ntusi NB, Badri M, Gumedze F, Wonkam A, Mayosi BM. Clinical characteristics and outcomes of familial and idiopathic dilated cardiomyopathy in Cape Town: a comparative study of 120 cases followed up over 14 years. South African Medical Journal. 2011; 101(6): 399–404.